全文获取类型
收费全文 | 5673篇 |
免费 | 339篇 |
国内免费 | 36篇 |
学科分类
医药卫生 | 6048篇 |
出版年
2024年 | 5篇 |
2023年 | 63篇 |
2022年 | 44篇 |
2021年 | 223篇 |
2020年 | 133篇 |
2019年 | 188篇 |
2018年 | 245篇 |
2017年 | 124篇 |
2016年 | 153篇 |
2015年 | 162篇 |
2014年 | 197篇 |
2013年 | 239篇 |
2012年 | 416篇 |
2011年 | 490篇 |
2010年 | 250篇 |
2009年 | 198篇 |
2008年 | 340篇 |
2007年 | 366篇 |
2006年 | 343篇 |
2005年 | 326篇 |
2004年 | 302篇 |
2003年 | 280篇 |
2002年 | 265篇 |
2001年 | 64篇 |
2000年 | 61篇 |
1999年 | 68篇 |
1998年 | 51篇 |
1997年 | 40篇 |
1996年 | 30篇 |
1995年 | 25篇 |
1994年 | 37篇 |
1993年 | 30篇 |
1992年 | 43篇 |
1991年 | 31篇 |
1990年 | 22篇 |
1989年 | 27篇 |
1988年 | 25篇 |
1987年 | 32篇 |
1986年 | 27篇 |
1985年 | 16篇 |
1984年 | 11篇 |
1983年 | 10篇 |
1982年 | 6篇 |
1980年 | 3篇 |
1975年 | 3篇 |
1974年 | 4篇 |
1972年 | 3篇 |
1969年 | 5篇 |
1968年 | 4篇 |
1967年 | 3篇 |
排序方式: 共有6048条查询结果,搜索用时 531 毫秒
1.
2.
3.
Yasushi Sawayama Hidehiro Itonaga Takuya Fukushima Nobuaki Nakano Hiroshi Fujiwara Atae Utsunomiya Takahiro Fukuda Toshihiro Miyamoto Tetsuya Eto Kaname Miyashita Hirohisa Nakamae Masao Ogata Atsushi Yamanoha Yasuhiko Miyazaki Junya Kanda Yoshiko Atsuta Koji Kato ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation 《American journal of hematology》2019,94(5):E143-E146
4.
Eriko Yanagida Hiroaki Miyoshi Mai Takeuchi Noriaki Yoshida Kazutaka Nakashima Kyohei Yamada Takeshi Umeno Yasumasa Shimasaki Takuya Furuta Masao Seto Koichi Ohshima 《Hematological oncology》2020,38(5):680-688
The interaction of CD47 and signal-regulatory protein alpha (SIRPα) induces “don't eat me signal”, leading suppression of phagocytosis. This signal can affect the clinical course of malignant disease. Although CD47 and SIRPα expression are associated with clinicopathological features in several neoplasms, the investigation for adult T-cell leukemia/lymphoma (ATLL) has not been well-documented. This study aimed to declare the association between CD47 and SIRPα expression and clinicopathological features in ATLL. We performed immunostaining on 73 biopsy samples and found that CD47 is primarily expressed in tumor cells, while SIRPα is expressed in non-neoplastic stromal cells. CD47 positive cases showed significantly higher FoxP3 (P = .0232) and lower CCR4 (P = .0214). SIRPα positive cases presented significantly better overall survival than SIRPα negative cases (P = .0132). SIRPα positive cases showed significantly HLA class I (P = .0062), HLA class II (P = .0133), microenvironment PD-L1 (miPD-L1) (P = .0032), and FoxP3 (P = .0229) positivity. In univariate analysis, SIRPα expression was significantly related to prognosis (Hazard ratio [HR] 0.470; 95% confidence interval [CI] 0.253-0.870; P = .0167], although multivariate analysis did not show SIPRα as an independent prognostic factor. The expression of SIRPα on stromal cells reflects activated immune surveillance mechanism in tumor microenvironment and induce good prognosis in ATLL. More detailed studies for gene expression or genomic abnormalities will disclose clinical and biological significance of the CD47 and SIRPα in ATLL. 相似文献
5.
6.
7.
8.
Hisato Takagi Toshiyuki Tanabashi Norikazu Kawai Takuya Umemoto 《European journal of cardio-thoracic surgery》2007,32(2):400; author reply 400-400; author reply 401
9.
10.
A dosage study of the effect of the 21-aminosteroid U74006F on chronic cerebral vasospasm in a primate model 总被引:1,自引:0,他引:1
The efficacy of the 21-aminosteroid U74006F was investigated using different dosages in a restricted, randomized, placebo-controlled trial. Forty cynomolgous monkeys were divided into five groups of eight. There were two groups given treatment with placebos, one being saline and the other the vehicle in which U74006F was delivered. There were three U74006F treatment dosage groups: 0.3, 1.0, and 3.0 mg/kg. Each monkey underwent baseline cerebral angiography followed by right-sided craniectomy and subarachnoid placement of a clot around the middle cerebral artery (MCA). Treatment was administered intravenously every 8 hours for 6 days. Seven days after experimental subarachnoid hemorrhage, angiography was repeated, and the animals were killed. In both saline or vehicle placebo treatment groups, significant vasospasm (VSP) occurred on the clot side in the extradural internal carotid artery (C3), the intradural internal carotid artery, the precommunicating segment of the anterior cerebral artery (A1,) and the MCA (P less than 0.01). After U74006F treatment, significantly less VSP developed in the A1 on the clot side (0.3 mg/kg U74006F treatment group) and the MCA (all U74006F treatment groups, P less than 0.05). When the percentages of change from the baseline for the vessel diameters on the clot side were compared, VSP was attenuated in the A1 (P less than 0.05) and MCA (P less than 0.001) of all U74006F treatment groups as compared with the placebo treatment groups. Only 0.3 mg/kg of U74006F significantly prevented VSP in C3 (P less than 0.01). Although the 0.3 mg/kg dosage appeared to have the most favorable effect, no significant differences were observed among the three dosage groups. Electron microscopy of the MCA on the clot side in the animals treated with U74006F still showed luminal convolutions and morphological changes in the endothelial cells. These changes appeared less prominent in those MCAs with milder VSP. If these results in primates are applicable to humans, U74006F would be useful in reducing VSP after aneurysmal subarachnoid hemorrhage. 相似文献